{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T16:24:28Z","timestamp":1785687868044,"version":"3.56.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Pediatric Surgery"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.sempedsurg.2020.150974","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T16:21:28Z","timestamp":1600878088000},"page":"150974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Overgrowth syndromes and new therapies"],"prefix":"10.1016","volume":"29","author":[{"given":"Whitney","family":"Eng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne M.","family":"Hammill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise M.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.sempedsurg.2020.150974_bib0001","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3257","article-title":"Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies","volume":"137","author":"Adams","year":"2016","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.sempedsurg.2020.150974_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCD.0b013e328317a716","article-title":"Characterization of a distinct syndrome that associates complex truncal overgrowth, vascular, and acral anomalies: a descriptive study of 18 cases of CLOVES syndrome","volume":"18","author":"Alomari","year":"2009","journal-title":"Clin Dysmorphol"},{"issue":"2","key":"10.1016\/j.sempedsurg.2020.150974_bib0003","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.a.36836","article-title":"PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation","volume":"167A","author":"Keppler-Noreuil","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"6","key":"10.1016\/j.sempedsurg.2020.150974_bib0004","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.05.006","article-title":"Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome","volume":"90","author":"Kurek","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.sempedsurg.2020.150974_bib0005","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13073-020-0714-y","article-title":"The paradox of cancer genes in non-malignant conditions: implications for precision medicine","volume":"12","author":"Adashek","year":"2020","journal-title":"Genome Med"},{"issue":"7711","key":"10.1016\/j.sempedsurg.2020.150974_bib0006","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","article-title":"Targeted therapy in patients with PIK3CA-related overgrowth syndrome","volume":"558","author":"Venot","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.sempedsurg.2020.150974_bib0007","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jpag.2019.07.003","article-title":"Alpelisib treatment for genital vascular malformation in a patient with congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal\/skeletal anomalies and\/or scoliosis (CLOVES) syndrome","volume":"32","author":"L\u00f3pez Guti\u00e9rrez","year":"2019","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"10","key":"10.1016\/j.sempedsurg.2020.150974_bib0008","article-title":"The novel phosphatidylinositol-3-kinase (PI3K) inhibitor alpelisib effectively inhibits growth of PTEN-haploinsufficient lipoma cells","volume":"11","author":"Kirstein","year":"2019","journal-title":"Cancers Basel"},{"issue":"7","key":"10.1016\/j.sempedsurg.2020.150974_bib0009","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1104017","article-title":"A mosaic activating mutation in AKT1 associated with the Proteus syndrome","volume":"365","author":"Lindhurst","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.sempedsurg.2020.150974_bib0010","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/jmg.35.11.881","article-title":"Germline PTEN mutations in Cowden syndrome-like families","volume":"35","author":"Marsh","year":"1998","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.sempedsurg.2020.150974_bib0011","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/hmg\/7.3.507","article-title":"Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation","volume":"7","author":"Marsh","year":"1998","journal-title":"Hum Mol Genet"},{"issue":"8","key":"10.1016\/j.sempedsurg.2020.150974_bib0012","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/hmg\/8.8.1461","article-title":"PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome","volume":"8","author":"Marsh","year":"1999","journal-title":"Hum Mol Genet"},{"issue":"9298","key":"10.1016\/j.sempedsurg.2020.150974_bib0013","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S0140-6736(01)07110-0","article-title":"PTEN mutations and proteus syndrome","volume":"358","author":"Eng","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.sempedsurg.2020.150974_bib0014","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/humu.10257","article-title":"PTEN: one gene, many syndromes","volume":"22","author":"Eng","year":"2003","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.sempedsurg.2020.150974_bib0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.gde.2005.03.004","article-title":"RASA1: variable phenotype with capillary and arteriovenous malformations","volume":"15","author":"Boon","year":"2005","journal-title":"Curr Opin Genet Dev"},{"issue":"7","key":"10.1016\/j.sempedsurg.2020.150974_bib0016","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/humu.20746","article-title":"Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations","volume":"29","author":"Revencu","year":"2008","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.sempedsurg.2020.150974_bib0017","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/j.sempedsurg.2014.06.013","article-title":"Overgrowth syndromes with complex vascular anomalies","volume":"23","author":"Uller","year":"2014","journal-title":"Semin Pediatr Surg"},{"issue":"2","key":"10.1016\/j.sempedsurg.2020.150974_bib0018","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jtcvs.2010.04.023","article-title":"CLOVES syndrome with thoracic and central phlebectasia: increased risk of pulmonary embolism","volume":"140","author":"Alomari","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.sempedsurg.2020.150974_bib0019","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jvir.2010.01.013","article-title":"Diversion venography\u2013a modified technique in Klippel-Trenaunay syndrome: initial experience","volume":"21","author":"Alomari","year":"2010","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"10.1016\/j.sempedsurg.2020.150974_bib0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jvsv.2018.01.015","article-title":"Pulmonary thromboembolic events in patients with congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal\/skeletal abnormalities and Klippel-Tr\u00e9naunay syndrome","volume":"6","author":"Reis","year":"2018","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"1","key":"10.1016\/j.sempedsurg.2020.150974_bib0021","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cps.2010.08.009","article-title":"Management of combined vascular malformations","volume":"38","author":"Kulungowski","year":"2011","journal-title":"Clin Plast Surg"},{"issue":"6","key":"10.1016\/j.sempedsurg.2020.150974_bib0022","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/jpsu.2000.6947","article-title":"Endorectal pull-through abates gastrointestinal hemorrhage from colorectal venous malformations","volume":"35","author":"Fishman","year":"2000","journal-title":"J Pediatr Surg"},{"issue":"4","key":"10.1016\/j.sempedsurg.2020.150974_bib0023","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1053\/j.sempedsurg.2014.07.003","article-title":"Management of visceral vascular anomalies","volume":"23","author":"Dasgupta","year":"2014","journal-title":"Semin Pediatr Surg"},{"issue":"10","key":"10.1016\/j.sempedsurg.2020.150974_bib0024","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3174\/ajnr.A2349","article-title":"Complex spinal-paraspinal fast-flow lesions in CLOVES syndrome: analysis of clinical and imaging findings in 6 patients","volume":"32","author":"Alomari","year":"2011","journal-title":"Am J Neuroradiol"},{"issue":"12","key":"10.1016\/j.sempedsurg.2020.150974_bib0025","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.jhsa.2013.08.120","article-title":"CLOVES syndrome","volume":"38","author":"Bloom","year":"2013","journal-title":"J Hand Surg Am"},{"issue":"2","key":"10.1016\/j.sempedsurg.2020.150974_bib0026","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ajmg.a.32632","article-title":"CLOVE(S) syndrome: expanding the acronym","volume":"149A","author":"Alomari","year":"2009","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.sempedsurg.2020.150974_bib0027","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ajmg.c.31735","article-title":"Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome","volume":"181","author":"Keppler-Noreuil","year":"2019","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"10.1016\/j.sempedsurg.2020.150974_bib0028","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ajmg.c.31531","article-title":"Somatic overgrowth disorders of the PI3K\/AKT\/mTOR pathway & therapeutic strategies","volume":"172","author":"Keppler-Noreuil","year":"2016","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"2","key":"10.1016\/j.sempedsurg.2020.150974_bib0029","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10048-018-0540-1","article-title":"In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)","volume":"19","author":"Ranieri","year":"2018","journal-title":"Neurogenetics"},{"issue":"1","key":"10.1016\/j.sempedsurg.2020.150974_bib0030","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/BPO.0b013e3182a1f0b8","article-title":"Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity","volume":"34","author":"Alomari","year":"2014","journal-title":"J Pediatr Orthop"},{"issue":"3","key":"10.1016\/j.sempedsurg.2020.150974_bib0031","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1097\/BPO.0000000000001406","article-title":"Surgical management of fibroadipose vascular anomaly of the lower extremities","volume":"40","author":"Wang","year":"2020","journal-title":"J Pediatr Orthop"},{"issue":"8","key":"10.1016\/j.sempedsurg.2020.150974_bib0032","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00247-016-3576-0","article-title":"Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option","volume":"46","author":"Shaikh","year":"2016","journal-title":"Pediatr Radiol"},{"issue":"4","key":"10.1016\/j.sempedsurg.2020.150974_bib0033","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jaad.2013.05.030","article-title":"Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy","volume":"69","author":"Lee","year":"2013","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.sempedsurg.2020.150974_bib0034","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jaad.2017.06.014","article-title":"Wilms tumor screening in diffuse capillary malformation with overgrowth and macrocephaly-capillary malformation: a retrospective study","volume":"77","author":"Peterman","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.sempedsurg.2020.150974_bib0035","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10456-016-9538-1","article-title":"A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth","volume":"20","author":"Couto","year":"2017","journal-title":"Angiogenesis"},{"issue":"5","key":"10.1016\/j.sempedsurg.2020.150974_bib0036","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/cge.13702","article-title":"Diffuse capillary malformation with overgrowth contains somatic PIK3CA variants","volume":"97","author":"Goss","year":"2020","journal-title":"Clin Genet"},{"issue":"7","key":"10.1016\/j.sempedsurg.2020.150974_bib0037","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00403-008-0842-5","article-title":"A novel mutation in RASA1 causes capillary malformation and limb enlargement","volume":"300","author":"Hershkovitz","year":"2008","journal-title":"Arch Dermatol Res"},{"issue":"10","key":"10.1016\/j.sempedsurg.2020.150974_bib0038","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/s41431-018-0196-1","article-title":"Expanding the clinical and molecular findings in RASA1 capillary malformation-arteriovenous malformation","volume":"26","author":"Wooderchak-Donahue","year":"2018","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.sempedsurg.2020.150974_bib0039","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/ijd.12040","article-title":"Capillary malformation-arteriovenous malformation: a clinical review of 45 patients","volume":"53","author":"Larralde","year":"2014","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.sempedsurg.2020.150974_bib0040","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0268355516664212","article-title":"Parkes Weber syndrome-diagnostic and management paradigms: a systematic review","volume":"32","author":"Banzic","year":"2017","journal-title":"Phlebology"},{"key":"10.1016\/j.sempedsurg.2020.150974_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.avsg.2020.05.039","article-title":"Embolization techniques for arteriovenous malformations in Parkes-Weber syndrome","author":"Conway","year":"2020","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.sempedsurg.2020.150974_bib0042","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.07.2008.0546","article-title":"High output heart failure caused by extensive arteriovenous malformation: problems and pregnancy","author":"Dubrey","year":"2009","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.sempedsurg.2020.150974_bib0043","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.medcli.2013.01.009","article-title":"[High-output cardiac failure due to congenital arteriovenous fistula. Parkes Weber syndrome]","volume":"141","author":"Epelde","year":"2013","journal-title":"Med Clin Barc"},{"issue":"12","key":"10.1016\/j.sempedsurg.2020.150974_bib0044","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/humu.22431","article-title":"RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation","volume":"34","author":"Revencu","year":"2013","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.sempedsurg.2020.150974_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejmg.2011.11.008","article-title":"RASA1 analysis: clinical and molecular findings in a series of consecutive cases","volume":"55","author":"Wooderchak-Donahue","year":"2012","journal-title":"Eur J Med Genet"},{"issue":"1","key":"10.1016\/j.sempedsurg.2020.150974_bib0046","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/jmedgenet-2019-106024","article-title":"mosaic mutations in patients with capillary malformation-arteriovenous malformation","volume":"57","author":"Revencu","year":"2020","journal-title":"J Med Genet"},{"issue":"9","key":"10.1016\/j.sempedsurg.2020.150974_bib0047","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/s41436-019-0443-z","article-title":"Phenotype of CM-AVM2 caused by variants in EPHB4: how much overlap with hereditary hemorrhagic telangiectasia (HHT)","volume":"21","author":"Wooderchak-Donahue","year":"2019","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.sempedsurg.2020.150974_bib0048","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jmoldx.2017.04.001","article-title":"Overgrowth syndromes caused by somatic variants in the phosphatidylinositol 3-kinase\/AKT\/mammalian target of rapamycin pathway","volume":"19","author":"Akgumus","year":"2017","journal-title":"J Mol Diagn"},{"issue":"1","key":"10.1016\/j.sempedsurg.2020.150974_bib0049","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.det.2016.07.001","article-title":"Mosaic disorders of the PI3K\/PTEN\/AKT\/TSC\/mTORC1 signaling pathway","volume":"35","author":"Nathan","year":"2017","journal-title":"Dermatol Clin"},{"issue":"7","key":"10.1016\/j.sempedsurg.2020.150974_bib0050","first-page":"508","article-title":"[A clinical study of Proteus syndrome caused by a mosaic somatic mutation in AKT1 gene]","volume":"58","author":"Xu","year":"2019","journal-title":"Zhonghua Nei Ke Za Zhi"}],"container-title":["Seminars in Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055858620300949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055858620300949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T02:33:02Z","timestamp":1602729182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055858620300949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1055858620300949"],"URL":"https:\/\/doi.org\/10.1016\/j.sempedsurg.2020.150974","relation":{},"ISSN":["1055-8586"],"issn-type":[{"value":"1055-8586","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overgrowth syndromes and new therapies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sempedsurg.2020.150974","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"150974"}}